Licence for Botox in so-called chronic migraine

The Lancet

Volumn 376, Issue 9755, 2010, Pages 1825-1826

  Olesen, Jes ^a   Tfelt Hansen, Peer ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; PLACEBO; PROPRANOLOL;

CLINICAL TRIAL; DISEASE CLASSIFICATION; DRUG APPROVAL; DRUG USE; EPISODIC TENSION HEADACHE; FACIAL EXPRESSION; HUMAN; LETTER; LICENCE; MUSCLE WEAKNESS; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; TENSION HEADACHE; TRANSFORMED MIGRAINE;

EID: 78649461297     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)62165-4     Document Type: Letter

References (5)

1. S Evers, J Olesen Botulinum toxin in headache treatment: the end of the road? Cephalalgia 26 2006 769 771
2. SK Aurora, DW Dodick, CC Turkel OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Cephalalgia 30 2010 793 803
3. HC Diener, DW Dodick, SK Aurora OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Cephalalgia 30 2010 804 814
4. DW Dodick, CC Turkel, RE DeGryse OnabotulinumtoxinA for treatment for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program Headache 50 2010 921 936
5. Headache Classification Committee of the International Headache Society The international classification of headache disorders, 2nd edn Cephalalgia 24 suppl 1 2004 9 160